2001
DOI: 10.1177/009286150103500225
|View full text |Cite
|
Sign up to set email alerts
|

The Emerging Role of Medical Affairs within the Modern Pharmaceutical Company

Abstract: Printed i n the USA. All rights reserved.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2007
2007
2008
2008

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…The medical communication groups responsibilities support drug commercialization through the development and conduct of education symposiums; as medical advisor to speaker training, advisory boards, investigator meetings, and pharmaceutical compendia generation; publication planning; scientific meeting support and competitive intelligence gathering; field tool development and training resource (Fig. 11.18) [53][54][55][56].…”
Section: Fig 1117 Cme and Phrma Code Of Practicementioning
confidence: 99%
See 1 more Smart Citation
“…The medical communication groups responsibilities support drug commercialization through the development and conduct of education symposiums; as medical advisor to speaker training, advisory boards, investigator meetings, and pharmaceutical compendia generation; publication planning; scientific meeting support and competitive intelligence gathering; field tool development and training resource (Fig. 11.18) [53][54][55][56].…”
Section: Fig 1117 Cme and Phrma Code Of Practicementioning
confidence: 99%
“…Although not required, a written agreement, coupled with the factors described in Figure 11.20, can provide valuable evidence as to whether an activity is independent and nonpromotional [12,[50][51][52][53].…”
Section: Ahfs-drug Information Essentialsmentioning
confidence: 99%
“…Table 5 outlines possible informational, educational, or research activities divided into clinical programs and marketing support programs, which are standard in the industry for MA units. They have been well described in the pharmaceutical literature, especially Drug Information Association publications (14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30). No start-up company has enough resources and time to plan and initiate them all, so that priorities need to be established and programs rolled out over time based on needs, resources, and capabilities.…”
Section: Strategic Engagement Of Medical Affairs For Launchmentioning
confidence: 99%
“…2 This in turn allows MSLs to foster compliant, collaborative relationships with various internal stakeholders. 3 In most companies, MSLs report into a Medical Affairs Department, and MSLs usually have advanced degrees in a scientifi c or medical discipline. While MSL responsibilities can differ from company to company, 4 a consistent focus is to build scientifi c excellence and help to advance patient care.…”
Section: Introductionmentioning
confidence: 99%